Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Thierry Gorlia, PhD"'
Autor:
Chandrakanth Jayachandran Preetha, MSc, Hagen Meredig, MD, Gianluca Brugnara, MD, Mustafa A Mahmutoglu, MD, Martha Foltyn, MD, Fabian Isensee, PhD, Tobias Kessler, MD, Irada Pflüger, MD, Marianne Schell, MD, Ulf Neuberger, MD, Jens Petersen, PhD, Antje Wick, MD, Sabine Heiland, ProfPhD, Jürgen Debus, ProfMD, Michael Platten, ProfMD, Ahmed Idbaih, MD, Alba A Brandes, ProfMD, Frank Winkler, ProfMD, Martin J van den Bent, ProfMD, Burt Nabors, ProfMD, Roger Stupp, ProfMD, Klaus H Maier-Hein, ProfPhD, Thierry Gorlia, PhD, Jörg-Christian Tonn, ProfMD, Michael Weller, ProfMD, Wolfgang Wick, ProfMD, Martin Bendszus, ProfMD, Philipp Vollmuth, MD
Publikováno v:
The Lancet: Digital Health, Vol 3, Iss 12, Pp e784-e794 (2021)
Summary: Background: Gadolinium-based contrast agents (GBCAs) are widely used to enhance tissue contrast during MRI scans and play a crucial role in the management of patients with cancer. However, studies have shown gadolinium deposition in the brai
Externí odkaz:
https://doaj.org/article/1d0604c10cd74d3aaeb41f01be7c60b0
Autor:
Polley MC; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Gorlia T; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Lassman AB; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van den Bent MJ; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; Thierry Gorlia, PhD, EORTC, Brussels, Belgium; Andy B. Lassman, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, NewYork-Presbyterian Hospital, New York, NY; and Martin J. van den Bent, MD, Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 01; Vol. 41 (4), pp. 934-935. Date of Electronic Publication: 2022 Oct 03.